- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02771015
Performance of Flexible Self-adherent Absorbent Dressing Coated With a Soft Silicone Layer After Hip -,Knee- Arthroplasty,Primary Spine Surgery in Comparison to a Standard Wound Dressing (wounddressing)
May 10, 2016 updated by: Jan Bredow, University of Cologne
A Mono-centre, Post CE-mark, Prospective-randomized Clinical Trial to Evaluate the Performance of a Flexible Self-adherent Absorbent Dressing Coated With a Soft Silicone Layer After Hip or Knee Arthroplasty or Primary Spine Surgery in Comparison to a Standard Wound Dressing (Cosmopor E®Steril, Fa. Hartmann)
Male or female subjects, 18 years and above, undergoing hip, knee or spinal surgery with an expected hospital stay for 4 days or more will be included in the trial.
Individual trial duration will be for 7 days (follow-up).
Two hundred subjects will be included in the trial, i.e. 100 subjects per arm.
The treatment arm (either new or standard wound dressing) will be assigned by randomization stratified by type of surgery (i.e.
hip, knee or spine).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
At the baseline visit:
- Subject demographic details
- Inclusion and exclusion criteria
- Vital signs
- Medical and surgical history
- Skin status at incision site
- Mobilisation (subject mobility, mobilisation in bed and chair)
- Medication
- AE/ADE/ SAE/SADE/DD
- Informed consent
- Randomization
At visit 2:
- Type of surgery
- Length of incision
- Intraoperative antibiotic given
- Length of anesthesia
At each visit from visit 3:
- Surgical incision condition (condition under the dressing, condition outside the dressing, exudates amount, exudates nature, wound odour, dressing capacity of handling blood, signs of systemic infection, systemic antibiotic given for the systematic infection, blistering, skin stripping
- Skin status at incision site (type of skin, skin temperature, skin perspiration, oedema, tissue consistency, sensation)
- Mobilisation (subject mobility, mobilisation in bed and chair)
- Dressing change (application and removal)
- Drainage (drainage used, application of the drainage)
- Compression Medication (pain medication and systematic antibiotic treatment)
- Photo (photo before and after dressing removal and if signs of infection)
- Investigator/nurse evaluation (ease of application of the dressing, size of the dressing, shape of the dressing, visibility beneath the dressing, notice any pain at dressing change, ease of removal of the dressing, overall experience)
- Patient evaluation (the patient's overall experience of the dressing, comfort when wearing the dressing).
- Contentious pain - measured by Visual Analog Scale (VAS) Prüfplan: CLOSE 2.0F 28.10.2013 5(40)
- Product application (time application start, time application ended, staff involved, material)
- AE/ADE/SAE/SADE/DD
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
NRW
-
Cologne, NRW, Germany, 50931
- University Hospital Cologne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age ≥18years
- Have an expected total length of stay of 4 or more days
- Undergoing elective primary arthroplasty of the hip or knee or spinal surgery
- Undergoing hip surgery with a standard access
- Give their written informed consent to participate
Exclusion Criteria:
- Dressing size does not fit the incision area
- Known allergy/hypersensitivity to any of the components of the dressing
- Multi-trauma
- Undergoing arthroplasty due to tumor
- Fractures
- Wound at the surgical site prior to surgery
- Neurological deficit of operated side (hemiplegia, etc.)
- Subject has documented skin disease at time of enrolment, as judged by the investigator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Mepilex Border®
Mepilex Border® wound dressing at patients after hip-knee or primary spine surgery
|
randomization
|
|
ACTIVE_COMPARATOR: Cosmopor steril®
Standard wound dressing at patients after hip-knee or primary spine surgery
|
randomization
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Minimize the Risk of the Development of Blistering
Time Frame: 7 days after surgery
|
Number of participants without blisters at study visit
|
7 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Rated 'Very Good to Excellent' for Comfort, Conformability and the Acceptability of the Dressing
Time Frame: 7 days
|
The comfort, conformability and the acceptability of the dressing were measured on all visit in the study, by a study nurses.
The patient had to answer questions regarding, the size of the dressing, shape of the dressing, Visibility beneath the dressing, ease of the application of the dressing, ease of removal of the dressing, overall experience of the use of the dressing, notice any pain at dressing change, Comfort of their dressing, overall experience of their dressing.
The patient could chose between 1 Good, 2 Very good, 3 Excellent.In most cases, the patient chose very good to excellent for both hip and knee surgery
|
7 days
|
|
Comfort, Comformability, Acceptability of the Dressing
Time Frame: 7 days
|
The comfort, conformability and the acceptability of the dressing were measured on all visit in the study, by a study nurses.
The patient had to answer questions regarding, the size of the dressing, shape of the dressing, Visibility beneath the dressing, ease of the application of the dressing, ease of removal of the dressing, overall experience of the use of the dressing, notice any pain at dressing change, Comfort of their dressing, overall experience of their dressing.
The patient could chose between 1 Good, 2 Very good, 3 Excellent
|
7 days
|
|
Change From Baseline in Pain on the visual analog scale
Time Frame: 7 days
|
Scores range from 0 [no pain] to 10 [worst possible pain]
|
7 days
|
|
the overall cost regarding dressing wear time
Time Frame: 7 days
|
bill of material costs
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jan Bredow, University Hospital Cologne
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2014
Primary Completion (ACTUAL)
December 1, 2015
Study Completion (ACTUAL)
May 1, 2016
Study Registration Dates
First Submitted
September 8, 2015
First Submitted That Met QC Criteria
May 10, 2016
First Posted (ESTIMATE)
May 12, 2016
Study Record Updates
Last Update Posted (ESTIMATE)
May 12, 2016
Last Update Submitted That Met QC Criteria
May 10, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- Uni-Köln_2013-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spine Surgery
-
University of California, San FranciscoRecruitingPain | Spine | Spine Surgery | Spine Fusion | Spine Surgery With Neuromonitoring | Spine Surgery With Motor Evoked Potential MonitoringUnited States
-
Rothman Institute OrthopaedicsEnrolling by invitation
-
Surgify Medical OyCompletedSurgery | Spine SurgeryFinland
-
King Khalid University HospitalNot yet recruitingSpine SurgerySaudi Arabia
-
Advanced Scanners Inc.Enrolling by invitation
-
GCS Ramsay Santé pour l'Enseignement et la RechercheTerminated
-
Brigham and Women's HospitalCompleted
-
Albany Medical CollegeUnknown
-
Shahid Beheshti UniversityCompletedSpine SurgeryIran, Islamic Republic of
-
University of California, San FranciscoTerminated
Clinical Trials on Mepilex Border®
-
PD Dr. Jan KottnerCompletedPressure UlcerGermany
-
Melbourne HealthCompleted
-
University Hospital, Clermont-FerrandMolnlycke Health Care ABUnknownUlcer | Skin Ulcer | Prevention | Pressure UlcersFrance
-
Maastricht University Medical CenterCompletedGrade I to Grade IV Pressure Ulcers in Higher Risk PatientsNetherlands
-
Molnlycke Health Care ABCompleted
-
Molnlycke Health Care ABTerminatedWound HealUnited Kingdom, Belgium, Portugal
-
Molnlycke Health Care ABCompletedPressure Incidence PreventionUnited States
-
Molnlycke Health Care ABRecruiting
-
Taipei Medical University Shuang Ho HospitalUnknown
-
Charite University, Berlin, GermanyCompletedPressure Ulcer PreventionGermany